Table 6.
Polyphenol-loaded carbon-based nanohybrids for the treatment of cancer.
| No. | Components of Nanoparticles | Method of Preparation | Polyphenol + Synergistic Agent | Type of Cancer In Vitro Model/In Vivo Model Promisingly Treated with the Fabricated Nanotherapeutic Formulation | References |
|---|---|---|---|---|---|
| 1 | Graphene oxide | Reduction method | Tea polyphenols | Colon cancer HT29, SW48 | [133] |
| 2 | Graphene oxide | Reduction method | Resveratrol | Ovarian cancer A2780 | [134] |
| 3 | Polycapro-lactone–MWNT | Electrospinning | Tea polyphenols | Lung cancer A549 | [136] |
| 4 | Polycapro-lactone–MWNT | Electrospinning | Tea polyphenols | Hepatic HepG2 | [136] |
| 5 | Gelatin–MWNT | Coating | Catechin + Radiotherapy | Prostate cancer DY-145, PC-3, LNCap | [138] |
| 6 | Gelatin–MWNT | Coating | Catechin | Cervical cancer HeLa | [139] |
| 7 | Polymeth-acrylic acid–MWNT | Radical coupling | Quercetin | Cervical cancer HeLa | [137] |
| 8 | Polymeth-acrylic acid–MWNT | Radical coupling | Quercetin + Cisplatin | Neuroblastoma IMR-32 | [140] |
Note: MWNT—Multiple-walled carbon nanotubes.